SEC to Review Nasdaq Bitcoin Options Approval After CME Challenge

The U.S. Securities and Exchange Commission is set to review its approval of Nasdaq bitcoin options after a challenge from CME, according to CoinDesk.

The dispute centers on whether options tied to bitcoin should be overseen by the SEC or whether they fall under the Commodity Futures Trading Commission’s jurisdiction. CME’s argument is that bitcoin is a commodity, and therefore derivatives linked to its price should be regulated by the CFTC rather than the SEC.

The review adds another layer to the ongoing debate over how U.S. regulators classify and supervise digital asset products. Bitcoin itself has long been treated differently from securities in U.S. regulatory discussions, but financial products referencing it can still raise jurisdictional questions depending on structure and venue.

Nasdaq’s bitcoin options approval is now under scrutiny as a result of the challenge, though the available details do not make clear how quickly the SEC will act or whether the review could affect the product’s launch timeline. The extent of any market impact also remains uncertain at this stage.

The matter highlights the broader tension between two federal regulators that have both played roles in overseeing crypto-related products. The SEC typically focuses on securities and securities-based derivatives, while the CFTC regulates commodity futures and certain options markets. Where a bitcoin-linked instrument belongs can depend on the legal framing of the product, not just the underlying asset.

For market participants, the case is another reminder that regulatory clarity remains incomplete even for assets with the deepest trading history in crypto. Exchanges and clearing venues continue to seek pathways for listed products tied to bitcoin, but approvals can face objections when agency boundaries are contested.

CoinDesk reported the development on Aug. 1. Further details on the SEC’s review were not available in the source metadata provided.